Dodanim Talavera, PhD- Chief Scientist Officer for the Biopharma Division.
Dr. Talavera obtained his Masters and Doctorate degrees in Cellular Physiology and Molecular Biomedicine respectively at The Center for Research and Advances Studies in Mexico, City. During his PhD training, Dr. Talavera discovered novel pathophysiological effects of dengue virus on human endothelial cells. After finishing his PhD, Dr. Talavera worked in his first postdoctoral position at Cedars-Sinai Medical Center in Los Angeles, California, investigating the angiogenic effects of leptin. During his second postdoctoral position at the same Institution, Dr. Talavera discovered that human endothelial cells are able to induce in vitro differentiation of pluripotent stem cells to insulin producing cells through bone morphogenetic protein. Dr. Talavera then obtained a position as Assistant Professor of Surgery at Cedars-Sinai Medical Center and his investigation focused on the inductive effects of human endothelial cells in the differentiation of induced pluripotent stem cells to pancreatic beta cells. Dr. Talavera has written several peer-reviewed articles published in high impact Medical & Scientific journals and has been awarded with the “Rechmiel-Levine Scientific Achievement Award” by City of Hope in Los Angeles, CA, for his investigations in diabetes and obesity. At present, Dr. Talavera and his research team at RINATI SKIN are focused on the use of adipose-stem-cell secretory factors that can be applied in Regenerative Medicine to develop Biopharmaceutical agents. These agents will be used in therapies specifically designed to promote hair, bone, cartilage, and adipose tissue regeneration. In addition, Dr. Talavera and his team are collaborating with the Cosmetic Division at RINATI SKIN to develop novel Biopharmaceutical products based on cell-cell interactions between human and plant stem cells. These cell-cell interactions have vast potential and application in Biomedicine.
Harpreet Sidhu, PhD- Head Molecular Biology
Dr. Sidhu obtained her Bachelor’s degree in Biological Sciences from Nanyang Technological University in Singapore and her Doctorate degree in Neuroscience from the University of California, Riverside. During her doctorate training, Dr. Sidhu explored the pathology of several neurological disorders, focusing on the role of matrix metalloproteinases in Fragile X Syndrome (FXS). Her other focus involved Alzheimer’s disease. She investigated the role of Notch protein in angiogenesis and how angiogenesis affects the progression of Alzheimer’s disease using HUVEC cells in vitro and in a zebrafish model. After completing her PhD, Dr. Sidhu remained at UC Riverside for her first postdoctoral continuing her work on FXS, looking at auditory deficits in the mouse model of FXS. Her second postdoctoral position was at The Scripps Research Institute, La Jolla where she studied alcohol addiction, focusing on the molecular mechanisms underlying the switch from social drinking to dependence as well as the behavioral outputs of anxiety and irritability during withdrawal from alcohol in a rodent model. At present, Dr. Sidhu is studying the factors and signaling pathways influencing the differentiation of adipose-derived stem cells into different cell fates and possible mechanisms to allow for extended culturing of these stem cells.
PLANT METABOLIC DIVISION
Assaf Zemach, PhD- Head Metabolic Engineering
Dr. Zemach earned his PhD from the internationally renowned Weizmann Institute of Science. During his PhD studies, Dr. Zemach studied molecular and cellular mechanisms of gene regulatory factors in plants. He also developed a biotechnological tool to regulate the activity of transcription factors. Dr. Zemach did his postdoctoral fellowship in the Plant & Microbial Biology Department at the distinguished University of California, Berkeley. His research was focused on epigenomics, that is systematic profiling of genome regulatory mechanisms shared among plants and animals. Dr. Zemach was appointed to the faculty of the School of Plant Sciences and Food Security at Tel Aviv University. Dr. Zemach experimental and computational research group investigated molecular mechanisms, developmental roles, and evolutionary pathways of epigenetics. Dr. Zemach has joined the team at Rinati Skin as the Head of the Plant Metabolic Division, where he refines and engineers metabolic pathways.